Get started
AMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD)AMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD)AMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD)

AMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD)

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals Bonds

AMGND chart


Full chart

Key facts today


Amgen's stock dipped under 0.5% in premarket trading due to President Trump's tariff threats on the pharmaceutical sector, potentially reaching 200%.
Analyze the impactAnalyze the impact

Key stats


Market capitalization
‪157.28 B‬ USD
Dividend yield (indicated)
2.03%
Price to earnings Ratio (TTM)
35.12
Basic EPS (TTM)
0.33 USD
Net income (FY)
‪3.63 B‬ USD
Revenue (FY)
‪29.52 B‬ USD
Shares float
—
Beta (1Y)
0.02

About Amgen Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Robert A. Bradway
Website
amgen.com
Headquarters
Thousand Oaks
Founded
1980
ISIN
ARDEUT110665
FIGI
BBG000HDW649
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Check out other big names from the same industry as AMGND.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

AMGND news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

AMGND highest yielding bonds


US31162CY4
AMGEN 21/53
Yield to maturity
7.47%
Maturity date
Sep 1, 2053
US31162DC1
AMGEN 21/52
Yield to maturity
7.08%
Maturity date
Jan 15, 2052
US31162CS7
AMGEN 20/50
Yield to maturity
6.83%
Maturity date
Feb 21, 2050
US31162DG2
AMGEN 22/62
Yield to maturity
6.73%
Maturity date
Feb 22, 2062
AMGD
AMGEN 22/52
Yield to maturity
6.72%
Maturity date
Feb 22, 2052
US31162BP4
AMGEN 12/43
Yield to maturity
6.60%
Maturity date
May 15, 2043
US31162DA5
AMGEN 21/41
Yield to maturity
6.56%
Maturity date
Aug 15, 2041
US31162DQ0
AMGEN 23/30
Yield to maturity
6.49%
Maturity date
Mar 2, 2030
US31162CR9
AMGEN 20/40
Yield to maturity
6.48%
Maturity date
Feb 21, 2040
US31162DK3
AMGEN 22/53
Yield to maturity
6.40%
Maturity date
Mar 1, 2053
AMGT
AMGEN 17/48
Yield to maturity
6.40%
Maturity date
Jun 15, 2048

See all AMGND bonds 

Sparks


Curated watchlists where AMGND is featured.

See all sparks